Asthma ppt
•Download as PPTX, PDF•
4 likes•2,275 views
This document defines asthma as an airflow obstruction caused by bronchoconstriction from an allergic reaction. It discusses the two main types of asthma - extrinsic caused by allergies, and intrinsic of unknown cause. Risk factors include gender, family history, environmental allergens and stress. The pathophysiology involves inflammation and narrowing of the airways due to mast cell activation and mucus production, causing symptoms like wheezing and difficulty breathing. Diagnosis involves assessing history, symptoms, lung function tests, and imaging. Treatment consists of long-term and quick relief medications, and avoiding triggers. Nursing care focuses on monitoring breathing, vital signs, oxygen levels, and symptoms to assess asthma severity and response to treatment.
Report
Share
Report
Share
Recommended
Bronchial Asthma: Definition,Pathophysiology and Management
Definition and Pathophysiology of Asthma in addition to classification and recent updates in the management of asthma based on GINA-2019 Guidelines, by Dr. Marco Makram.
Bronchial asthama
BRONCHIAL ASTHMA
ntroduction
Definition
Etiological factors
Pathophysiology
Types of asthma
Clinical manifestation Restlessness Wheezing or crackles Absent or diminished lung sounds Hyper resonance Use of accessory muscles for breathing Tachypnea with hyperventilation
Clinical manifestation
Diagnostic evaluation
Bronchoprovocation Testing: Testing that is done to identify inhaled allergens; mucous membranes are directly exposed to suspected allergen in increasing amounts. Skin Testing: Done to identify specific allergens. Exercise Challenges: Exercise is used to identify the occurrence of exercise-induced bronchospasm. Radio allergosorbent Test: Blood test used to identify a specific allergen. Chest Radiograph: May show hyper expansion of the airways.
Managemnet
Goal- Promote bronchodilationn Reduce inflammation Remove secretions Prevent ongoing symptoms Prevent asthma attack Maintain normal lung function Avoid triggers
Pharmacological therapy 1. Long term control medication- Inhaled corticosteroid Leukotriene modifiers Long acting beta agonist Methylxanthines Combine inhaler
2 Quick relief medication Short acting beta agonist Anticholinergic Oral or I/V corticosteroid
3 Bronchial thermoplasty- Form severe asthma that does not respond to medication
Non- pharmacological
Oxygen therapy Postural drainage & chest physiotherapy Coughing & deep breathing exercise Avoidance of allergen relaxation technique acupuncture
Prevention
Patients with recurrent asthma should undergo tests to identify the substances that precipitate the symptoms. Possible causes are dust, dust mites, roaches, certain types of cloth, pets, horses, detergents, soaps, certain foods, molds, and pol- lens. If the attacks are seasonal, pollens can be strongly sus- pected. Patients are instructed to avoid the causative agents whenever possible.
Complications Complications of asthma may include status asthmaticus, respiratory failure, pneumonia, and atelectasis. Airway obstruction, particularly during acute asthmatic episodes, often results in hypoxemia, requiring the administration of oxygen and the monitoring of pulse oximetry and arterial blood gases. Fluids are administered, because people with asthma are frequently dehydrated from diaphoresis and in- sensible fluid loss with hyperventilation.
Nursing diagnosis
Impaired gas exchange r/t altered oxygen supply Ineffective airway clearance r/t bronchospasm & obstruction from narrow lumen Ineffective breathing pattern r/t bronchospasm Risk for increasing attack of r
espiratory distress r/t exposure to allergens
Asthma Pathophysiology N
1. Asthma is a chronic inflammatory disorder of the bronchi characterized by episodic and reversible bronchospasm caused by an exaggerated response to various stimuli like allergens.
2. It affects 10% of children and 5-7% of adults worldwide. The pathogenesis involves inflammation, airflow limitation, and airway hyperresponsiveness triggered by allergens, viruses, pollutants, and other factors.
3. New understanding of the role of leukotrienes, mast cells, eosinophils and cytokines in asthma pathology has led to more targeted drug therapies that inhibit these inflammatory pathways.
Bronchial Asthma by Dr. Sookun Rajeev Kumar
This document provides information on asthma, including its definition, types, pathophysiology, etiology, symptoms, diagnosis, and treatment. Asthma is defined as a chronic inflammatory disease of the airways characterized by variable airflow obstruction and airway hyperresponsiveness. It discusses the different types of asthma including allergic, non-allergic, cough variant, occupational, and exercise-induced asthma. Treatment involves both controller medications to reduce inflammation and reliver medications for acute symptoms. Treatment is escalated in steps based on asthma severity and control.
ASTHMA
Bronchial asthma is a chronic inflammatory disorder of the airways that causes recurrent episodes of wheezing, breathlessness, chest tightness and coughing. These episodes are usually associated with widespread but variable airflow obstruction that is often reversible with treatment. Asthma is characterized by airway inflammation, airway hyperresponsiveness, and reversible airway obstruction. Common triggers include allergens, infections, exercise, and environmental factors. Diagnosis involves assessing symptoms, performing pulmonary function tests to check for reversibility of airway obstruction, and ruling out other conditions.
Asthma
Asthma is a chronic inflammatory lung disease characterized by varying degrees of reversible airway obstruction. It is triggered by allergens, infections, pollution and other irritants. The pathophysiology involves bronchospasm and airway inflammation. Symptoms include wheezing, coughing, chest tightness and shortness of breath. Diagnosis is based on patient history and pulmonary function tests showing improved airflow after bronchodilator treatment. Management focuses on controlling triggers, medications to relieve symptoms and reduce inflammation, and patient education on proper use of inhalers.
Pathophysiology of Asthma
Asthma is a chronic inflammatory lung disease characterized by reversible airway obstruction. It is triggered by allergens, irritants, and infections. Chronic inflammation leads to narrowing of the airways. The signs and symptoms include wheezing, coughing, shortness of breath, and chest tightness. Risk factors include genetic and environmental factors. Triggers include allergens, viruses, exercise, and air pollutants. Chronic inflammation involves immune cells like mast cells, eosinophils, and T cells that release inflammatory mediators causing symptoms. Over time, structural changes in the airways can develop due to remodeling.
Asthma
This document provides an overview of asthma, including its definition, pathophysiology, clinical presentation, diagnosis, and management. It defines asthma as a chronic inflammatory disorder of the airways involving various cells. The pathophysiology involves acute and chronic inflammation from triggers like allergens. Diagnosis is based on symptoms, exam, and lung function tests showing reversible airflow obstruction. Management focuses on education, environmental control, and a stepped pharmacologic approach including bronchodilators and inhaled corticosteroids.
Recommended
Bronchial Asthma: Definition,Pathophysiology and Management
Definition and Pathophysiology of Asthma in addition to classification and recent updates in the management of asthma based on GINA-2019 Guidelines, by Dr. Marco Makram.
Bronchial asthama
BRONCHIAL ASTHMA
ntroduction
Definition
Etiological factors
Pathophysiology
Types of asthma
Clinical manifestation Restlessness Wheezing or crackles Absent or diminished lung sounds Hyper resonance Use of accessory muscles for breathing Tachypnea with hyperventilation
Clinical manifestation
Diagnostic evaluation
Bronchoprovocation Testing: Testing that is done to identify inhaled allergens; mucous membranes are directly exposed to suspected allergen in increasing amounts. Skin Testing: Done to identify specific allergens. Exercise Challenges: Exercise is used to identify the occurrence of exercise-induced bronchospasm. Radio allergosorbent Test: Blood test used to identify a specific allergen. Chest Radiograph: May show hyper expansion of the airways.
Managemnet
Goal- Promote bronchodilationn Reduce inflammation Remove secretions Prevent ongoing symptoms Prevent asthma attack Maintain normal lung function Avoid triggers
Pharmacological therapy 1. Long term control medication- Inhaled corticosteroid Leukotriene modifiers Long acting beta agonist Methylxanthines Combine inhaler
2 Quick relief medication Short acting beta agonist Anticholinergic Oral or I/V corticosteroid
3 Bronchial thermoplasty- Form severe asthma that does not respond to medication
Non- pharmacological
Oxygen therapy Postural drainage & chest physiotherapy Coughing & deep breathing exercise Avoidance of allergen relaxation technique acupuncture
Prevention
Patients with recurrent asthma should undergo tests to identify the substances that precipitate the symptoms. Possible causes are dust, dust mites, roaches, certain types of cloth, pets, horses, detergents, soaps, certain foods, molds, and pol- lens. If the attacks are seasonal, pollens can be strongly sus- pected. Patients are instructed to avoid the causative agents whenever possible.
Complications Complications of asthma may include status asthmaticus, respiratory failure, pneumonia, and atelectasis. Airway obstruction, particularly during acute asthmatic episodes, often results in hypoxemia, requiring the administration of oxygen and the monitoring of pulse oximetry and arterial blood gases. Fluids are administered, because people with asthma are frequently dehydrated from diaphoresis and in- sensible fluid loss with hyperventilation.
Nursing diagnosis
Impaired gas exchange r/t altered oxygen supply Ineffective airway clearance r/t bronchospasm & obstruction from narrow lumen Ineffective breathing pattern r/t bronchospasm Risk for increasing attack of r
espiratory distress r/t exposure to allergens
Asthma Pathophysiology N
1. Asthma is a chronic inflammatory disorder of the bronchi characterized by episodic and reversible bronchospasm caused by an exaggerated response to various stimuli like allergens.
2. It affects 10% of children and 5-7% of adults worldwide. The pathogenesis involves inflammation, airflow limitation, and airway hyperresponsiveness triggered by allergens, viruses, pollutants, and other factors.
3. New understanding of the role of leukotrienes, mast cells, eosinophils and cytokines in asthma pathology has led to more targeted drug therapies that inhibit these inflammatory pathways.
Bronchial Asthma by Dr. Sookun Rajeev Kumar
This document provides information on asthma, including its definition, types, pathophysiology, etiology, symptoms, diagnosis, and treatment. Asthma is defined as a chronic inflammatory disease of the airways characterized by variable airflow obstruction and airway hyperresponsiveness. It discusses the different types of asthma including allergic, non-allergic, cough variant, occupational, and exercise-induced asthma. Treatment involves both controller medications to reduce inflammation and reliver medications for acute symptoms. Treatment is escalated in steps based on asthma severity and control.
ASTHMA
Bronchial asthma is a chronic inflammatory disorder of the airways that causes recurrent episodes of wheezing, breathlessness, chest tightness and coughing. These episodes are usually associated with widespread but variable airflow obstruction that is often reversible with treatment. Asthma is characterized by airway inflammation, airway hyperresponsiveness, and reversible airway obstruction. Common triggers include allergens, infections, exercise, and environmental factors. Diagnosis involves assessing symptoms, performing pulmonary function tests to check for reversibility of airway obstruction, and ruling out other conditions.
Asthma
Asthma is a chronic inflammatory lung disease characterized by varying degrees of reversible airway obstruction. It is triggered by allergens, infections, pollution and other irritants. The pathophysiology involves bronchospasm and airway inflammation. Symptoms include wheezing, coughing, chest tightness and shortness of breath. Diagnosis is based on patient history and pulmonary function tests showing improved airflow after bronchodilator treatment. Management focuses on controlling triggers, medications to relieve symptoms and reduce inflammation, and patient education on proper use of inhalers.
Pathophysiology of Asthma
Asthma is a chronic inflammatory lung disease characterized by reversible airway obstruction. It is triggered by allergens, irritants, and infections. Chronic inflammation leads to narrowing of the airways. The signs and symptoms include wheezing, coughing, shortness of breath, and chest tightness. Risk factors include genetic and environmental factors. Triggers include allergens, viruses, exercise, and air pollutants. Chronic inflammation involves immune cells like mast cells, eosinophils, and T cells that release inflammatory mediators causing symptoms. Over time, structural changes in the airways can develop due to remodeling.
Asthma
This document provides an overview of asthma, including its definition, pathophysiology, clinical presentation, diagnosis, and management. It defines asthma as a chronic inflammatory disorder of the airways involving various cells. The pathophysiology involves acute and chronic inflammation from triggers like allergens. Diagnosis is based on symptoms, exam, and lung function tests showing reversible airflow obstruction. Management focuses on education, environmental control, and a stepped pharmacologic approach including bronchodilators and inhaled corticosteroids.
Bronchial Asthma
This document provides information on asthma, including its definition, epidemiology, etiology, pathogenesis, classification, symptoms, exacerbations, and atypical forms. Asthma is defined as a chronic inflammatory disease of the airways associated with bronchial hyperresponsiveness and reversible obstruction. It commonly involves eosinophilic inflammation and affects over 300 million people worldwide. Triggers include allergens, infections, pollution, and emotions. Pathogenesis typically involves a type I hypersensitivity reaction. Classification systems consider severity, control, and clinical course. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Exacerbations can be life-threatening without treatment.
Chronic obstructive pulmonary disease ppt
This document discusses chronic obstructive pulmonary disease (COPD) and asthma. It defines COPD as a progressive lung disease characterized by airflow limitation caused by damage to the lungs, usually from smoking. Risk factors include smoking, indoor pollution, occupational exposures, and genetic conditions. Symptoms include dyspnea, cough, and sputum production. Diagnosis involves pulmonary function tests showing reduced airflow. Treatment focuses on reducing symptoms and exacerbations through bronchodilators, anti-inflammatories, pulmonary rehabilitation, and managing exacerbations. Asthma is similarly characterized by variable and reversible airflow obstruction caused by inflammation. It has genetic and environmental triggers and is diagnosed through symptoms and pulmonary function testing showing reversibility. Treatment involves controlling triggers and a
Asthma pathogenesis
Asthma is a chronic inflammatory airway disease characterized by recurrent episodes of wheezing, breathlessness, chest tightness and coughing. The chronic inflammation causes airway hyperresponsiveness and airflow obstruction. Genetic and environmental factors contribute to its pathogenesis. Key features include eosinophilic inflammation, mast cell activation, cytokine production, and airway remodeling over time. Ongoing research seeks to better understand the complex immune and structural changes involved in order to develop new targeted treatments.
Asthma ppt
Bronchial asthma is a chronic inflammatory lung disease that causes narrowing of the airways. It is characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. Risk factors include allergens, air pollution, infections, stress, obesity, and family history. Symptoms are typically worse at night or early morning. Diagnosis involves assessing symptoms and lung function tests. Treatment focuses on preventing symptoms through avoidance of triggers and use of inhaled corticosteroids and bronchodilators. Nursing care emphasizes breathing treatments, monitoring for complications, patient education, and managing exacerbations.
Asthma
This document defines asthma and describes its types, symptoms, causes, risk factors, diagnosis, treatment and pathophysiology. Asthma is a chronic inflammatory lung disease characterized by airway hyperresponsiveness and reversible airflow obstruction. It is usually caused by allergic triggers like pollen or dust but can also be triggered by non-allergic factors like viruses or pollution. Diagnosis involves patient history, exams, lung function tests and allergy testing. Treatment includes bronchodilators, corticosteroids, leukotriene modifiers and immunotherapy. The pathophysiology involves type 2 inflammation, IgE production and eosinophil recruitment leading to bronchoconstriction.
Respiratory pathology
This document covers several topics related to respiratory pathophysiology:
1. It describes the anatomy and control of breathing, including the medullary respiratory center and pontine and apneustic areas.
2. Various types of breathing patterns are defined, such as Cheyne-Stokes respirations and Biot's respiration, along with the areas of brain injury that cause each pattern.
3. Common respiratory symptoms like cough, dyspnea, and hemoptysis are discussed alongside their typical causes.
4. Physical exam findings on chest auscultation and percussion are outlined, including vocal fremitus and lung sounds.
5. The calculation of the alveolar-arterial oxygen
Asthma
This document provides an overview of asthma, including:
- Asthma is characterized by variable and reversible airflow obstruction caused by airway inflammation and hyperresponsiveness.
- It affects 300 million people worldwide and prevalence is increasing. Genetic and environmental factors contribute to risk.
- Symptoms include wheezing, coughing, chest tightness and dyspnea triggered by factors like allergens, infections and exercise.
- Pathophysiology involves chronic inflammation, remodeling of the airways, and increased airway hyperresponsiveness.
- Diagnosis is based on symptoms and lung function tests, with treatment focusing on bronchodilators and inhaled corticosteroids.
Bronchial asthma
Bronchial asthma is a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness and coughing due to bronchospasm and airway obstruction. The symptoms are usually triggered by allergens, exercise, cold air or other stimuli and are at least partially reversible with treatment. It is caused by an inflammatory response in the airways mediated by TH2 cells and mast cells leading to increased mucus secretion, smooth muscle hypertrophy and bronchospasm. Common types include atopic asthma triggered by environmental allergens and non-atopic asthma triggered by respiratory infections.
Asthma
Adult asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction. It has been recognized since ancient times, with descriptions in Homer's Iliad and by Hippocrates. The understanding of asthma has evolved over centuries, with recognition of its inflammatory component in the 1960s. Asthma prevalence has increased 61% in recent decades and results in significant morbidity. It is classified based on severity and triggers. Pathophysiology involves airway inflammation, remodeling, and hyperresponsiveness. Common symptoms include cough, wheeze, chest tightness and shortness of breath. Physical exam may reveal wheezing and prolonged expiration.
Bronchial asthma
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
Asthma
This document provides an overview of asthma, including its pathophysiology, clinical presentation, diagnosis, and treatment. It defines asthma as a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchial hyperresponsiveness. The pathophysiology involves activation of mast cells and macrophages by inhaled allergens, leading to airway inflammation and constriction. Clinical presentations range from mild intermittent symptoms to severe acute exacerbations. Diagnosis is based on symptoms and spirometry showing reversible airflow obstruction. Treatment involves patient education, environmental control, pharmacotherapy including short-acting beta-agonists, and management of acute exacerbations with supplemental oxygen and hydration.
Bronchectasis
Bronchiectasis is a chronic lung disease defined by irreversible dilation of the bronchi. It develops from an initial event that impairs mucociliary clearance, allowing bacteria to colonize and further damage the lungs. The hallmark symptoms are a chronic cough and sputum production lasting months to years. Risk factors include cystic fibrosis, infections, immunodeficiencies, and exposures to toxic substances. Management involves antibiotics, airway clearance techniques, and supplemental oxygen. Severe cases may require surgery.
Bronchial asthma
Asthma is a chronic inflammatory airway disease characterized by bronchial hyperresponsiveness and reversible airflow limitation. The document traces the history of asthma from its first description in ancient Greek texts to modern recognition of its inflammatory pathophysiology. It then provides details on the definition, epidemiology, classification, pathogenesis, clinical features, investigations and management of asthma.
Emphysema
Emphysema is a condition that damages the air sacs in the lungs called alveoli, causing them to lose their elasticity and become enlarged. This makes breathing difficult. The main causes are smoking cigarettes and exposure to air pollution or dust. Symptoms include shortness of breath, coughing, and fatigue. Diagnosis involves medical history, physical exam, chest X-rays, and lung function tests. Treatment focuses on quitting smoking, using inhalers, oxygen therapy, exercise, and lifestyle changes. Managing the condition can help prevent further lung damage and associated complications.
Asthma
Asthma is a chronic inflammatory airway disease characterized by periods of reversible bronchospasm. Common triggers include allergens, irritants, and environmental factors. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Diagnosis involves assessing symptoms, lung function tests, and response to treatment. Management involves long-term control medications like inhaled corticosteroids and bronchodilators, as well as quick-relief medications for exacerbations. Treatment is tailored based on asthma severity and level of control.
Asthma by Farshid Mokhberi
This document defines and describes asthma. It begins by defining obstructive and restrictive lung diseases, with asthma being an obstructive disease. Asthma is then defined as a chronic inflammatory disorder of the airways characterized by inflammation, increased airway responsiveness, contraction of smooth muscles, hypersecretion of mucus, altered airway architecture and immunology. Asthma is classified as either intrinsic (non-allergic) or extrinsic (allergic). The pathophysiology and diagnosis of asthma are then discussed, followed by treatments which include short-acting beta agonists for acute symptoms and inhaled corticosteroids for chronic inflammation.
Pulmonary Diseases
This document provides an overview of pulmonary diseases including Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis. It describes the pathophysiology, signs and symptoms, diagnosis, and treatment of each condition. COPD is characterized by difficulty exhaling air and includes chronic bronchitis and emphysema. Asthma involves constricted airways, swollen bronchial linings, and excess mucus production. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and primarily affects the lungs, transmitted via airborne droplets.
Asthma
This document provides information about asthma, including its definition, prevalence, pathophysiology, clinical manifestations, diagnostic studies, management, and nursing considerations. Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms of wheezing, breathlessness, chest tightness, and cough. It affects over 300 million people globally. Management involves both long-term control medications and quick-relief medications. The goals of nursing management are to stabilize respiratory status, relieve symptoms, reduce anxiety, promote health, prevent complications, and prevent further asthma episodes.
Asthma
Asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction. It affects 300 million people worldwide and poses a large socioeconomic burden. The disease severity can range from intermittent to persistent daily symptoms. Common triggers include allergens, infections, pollution, and exercise. Diagnosis involves assessing symptoms, lung function testing, and allergy testing. Treatment involves avoidance of triggers, bronchodilators for relief of acute symptoms, and anti-inflammatory controllers like inhaled corticosteroids to prevent symptoms and exacerbations.
Asthma Pathogenesis
This document summarizes the pathology of asthma. It describes the anatomical changes that occur, including epithelial desquamation, thickening of the lamina reticularis, smooth muscle hypertrophy and hyperplasia, mucous gland hyperplasia, and angiogenesis. It also discusses the multicellular inflammation in asthma involving eosinophils, mast cells, macrophages, dendritic cells, lymphocytes, and neutrophils. The roles of these inflammatory cells and their mediators in contributing to asthma pathogenesis are described.
Bronchial asthma and management RRT
Made by Ranjith R Thampi. A decent powerpoint on Bronchial Asthma, a short summary on various presentations and treatment options starting at Primary health level. Was made mainly for Primary Health setup. I've also added options at higher centres and also a few references for latest drug modalities and use.
Bronchial asthma
"Prevention is better than cure" so that,it is important to get awareness about bronchial asthma and its prevention.
More Related Content
What's hot
Bronchial Asthma
This document provides information on asthma, including its definition, epidemiology, etiology, pathogenesis, classification, symptoms, exacerbations, and atypical forms. Asthma is defined as a chronic inflammatory disease of the airways associated with bronchial hyperresponsiveness and reversible obstruction. It commonly involves eosinophilic inflammation and affects over 300 million people worldwide. Triggers include allergens, infections, pollution, and emotions. Pathogenesis typically involves a type I hypersensitivity reaction. Classification systems consider severity, control, and clinical course. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Exacerbations can be life-threatening without treatment.
Chronic obstructive pulmonary disease ppt
This document discusses chronic obstructive pulmonary disease (COPD) and asthma. It defines COPD as a progressive lung disease characterized by airflow limitation caused by damage to the lungs, usually from smoking. Risk factors include smoking, indoor pollution, occupational exposures, and genetic conditions. Symptoms include dyspnea, cough, and sputum production. Diagnosis involves pulmonary function tests showing reduced airflow. Treatment focuses on reducing symptoms and exacerbations through bronchodilators, anti-inflammatories, pulmonary rehabilitation, and managing exacerbations. Asthma is similarly characterized by variable and reversible airflow obstruction caused by inflammation. It has genetic and environmental triggers and is diagnosed through symptoms and pulmonary function testing showing reversibility. Treatment involves controlling triggers and a
Asthma pathogenesis
Asthma is a chronic inflammatory airway disease characterized by recurrent episodes of wheezing, breathlessness, chest tightness and coughing. The chronic inflammation causes airway hyperresponsiveness and airflow obstruction. Genetic and environmental factors contribute to its pathogenesis. Key features include eosinophilic inflammation, mast cell activation, cytokine production, and airway remodeling over time. Ongoing research seeks to better understand the complex immune and structural changes involved in order to develop new targeted treatments.
Asthma ppt
Bronchial asthma is a chronic inflammatory lung disease that causes narrowing of the airways. It is characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. Risk factors include allergens, air pollution, infections, stress, obesity, and family history. Symptoms are typically worse at night or early morning. Diagnosis involves assessing symptoms and lung function tests. Treatment focuses on preventing symptoms through avoidance of triggers and use of inhaled corticosteroids and bronchodilators. Nursing care emphasizes breathing treatments, monitoring for complications, patient education, and managing exacerbations.
Asthma
This document defines asthma and describes its types, symptoms, causes, risk factors, diagnosis, treatment and pathophysiology. Asthma is a chronic inflammatory lung disease characterized by airway hyperresponsiveness and reversible airflow obstruction. It is usually caused by allergic triggers like pollen or dust but can also be triggered by non-allergic factors like viruses or pollution. Diagnosis involves patient history, exams, lung function tests and allergy testing. Treatment includes bronchodilators, corticosteroids, leukotriene modifiers and immunotherapy. The pathophysiology involves type 2 inflammation, IgE production and eosinophil recruitment leading to bronchoconstriction.
Respiratory pathology
This document covers several topics related to respiratory pathophysiology:
1. It describes the anatomy and control of breathing, including the medullary respiratory center and pontine and apneustic areas.
2. Various types of breathing patterns are defined, such as Cheyne-Stokes respirations and Biot's respiration, along with the areas of brain injury that cause each pattern.
3. Common respiratory symptoms like cough, dyspnea, and hemoptysis are discussed alongside their typical causes.
4. Physical exam findings on chest auscultation and percussion are outlined, including vocal fremitus and lung sounds.
5. The calculation of the alveolar-arterial oxygen
Asthma
This document provides an overview of asthma, including:
- Asthma is characterized by variable and reversible airflow obstruction caused by airway inflammation and hyperresponsiveness.
- It affects 300 million people worldwide and prevalence is increasing. Genetic and environmental factors contribute to risk.
- Symptoms include wheezing, coughing, chest tightness and dyspnea triggered by factors like allergens, infections and exercise.
- Pathophysiology involves chronic inflammation, remodeling of the airways, and increased airway hyperresponsiveness.
- Diagnosis is based on symptoms and lung function tests, with treatment focusing on bronchodilators and inhaled corticosteroids.
Bronchial asthma
Bronchial asthma is a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness and coughing due to bronchospasm and airway obstruction. The symptoms are usually triggered by allergens, exercise, cold air or other stimuli and are at least partially reversible with treatment. It is caused by an inflammatory response in the airways mediated by TH2 cells and mast cells leading to increased mucus secretion, smooth muscle hypertrophy and bronchospasm. Common types include atopic asthma triggered by environmental allergens and non-atopic asthma triggered by respiratory infections.
Asthma
Adult asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction. It has been recognized since ancient times, with descriptions in Homer's Iliad and by Hippocrates. The understanding of asthma has evolved over centuries, with recognition of its inflammatory component in the 1960s. Asthma prevalence has increased 61% in recent decades and results in significant morbidity. It is classified based on severity and triggers. Pathophysiology involves airway inflammation, remodeling, and hyperresponsiveness. Common symptoms include cough, wheeze, chest tightness and shortness of breath. Physical exam may reveal wheezing and prolonged expiration.
Bronchial asthma
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
Asthma
This document provides an overview of asthma, including its pathophysiology, clinical presentation, diagnosis, and treatment. It defines asthma as a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchial hyperresponsiveness. The pathophysiology involves activation of mast cells and macrophages by inhaled allergens, leading to airway inflammation and constriction. Clinical presentations range from mild intermittent symptoms to severe acute exacerbations. Diagnosis is based on symptoms and spirometry showing reversible airflow obstruction. Treatment involves patient education, environmental control, pharmacotherapy including short-acting beta-agonists, and management of acute exacerbations with supplemental oxygen and hydration.
Bronchectasis
Bronchiectasis is a chronic lung disease defined by irreversible dilation of the bronchi. It develops from an initial event that impairs mucociliary clearance, allowing bacteria to colonize and further damage the lungs. The hallmark symptoms are a chronic cough and sputum production lasting months to years. Risk factors include cystic fibrosis, infections, immunodeficiencies, and exposures to toxic substances. Management involves antibiotics, airway clearance techniques, and supplemental oxygen. Severe cases may require surgery.
Bronchial asthma
Asthma is a chronic inflammatory airway disease characterized by bronchial hyperresponsiveness and reversible airflow limitation. The document traces the history of asthma from its first description in ancient Greek texts to modern recognition of its inflammatory pathophysiology. It then provides details on the definition, epidemiology, classification, pathogenesis, clinical features, investigations and management of asthma.
Emphysema
Emphysema is a condition that damages the air sacs in the lungs called alveoli, causing them to lose their elasticity and become enlarged. This makes breathing difficult. The main causes are smoking cigarettes and exposure to air pollution or dust. Symptoms include shortness of breath, coughing, and fatigue. Diagnosis involves medical history, physical exam, chest X-rays, and lung function tests. Treatment focuses on quitting smoking, using inhalers, oxygen therapy, exercise, and lifestyle changes. Managing the condition can help prevent further lung damage and associated complications.
Asthma
Asthma is a chronic inflammatory airway disease characterized by periods of reversible bronchospasm. Common triggers include allergens, irritants, and environmental factors. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Diagnosis involves assessing symptoms, lung function tests, and response to treatment. Management involves long-term control medications like inhaled corticosteroids and bronchodilators, as well as quick-relief medications for exacerbations. Treatment is tailored based on asthma severity and level of control.
Asthma by Farshid Mokhberi
This document defines and describes asthma. It begins by defining obstructive and restrictive lung diseases, with asthma being an obstructive disease. Asthma is then defined as a chronic inflammatory disorder of the airways characterized by inflammation, increased airway responsiveness, contraction of smooth muscles, hypersecretion of mucus, altered airway architecture and immunology. Asthma is classified as either intrinsic (non-allergic) or extrinsic (allergic). The pathophysiology and diagnosis of asthma are then discussed, followed by treatments which include short-acting beta agonists for acute symptoms and inhaled corticosteroids for chronic inflammation.
Pulmonary Diseases
This document provides an overview of pulmonary diseases including Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis. It describes the pathophysiology, signs and symptoms, diagnosis, and treatment of each condition. COPD is characterized by difficulty exhaling air and includes chronic bronchitis and emphysema. Asthma involves constricted airways, swollen bronchial linings, and excess mucus production. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and primarily affects the lungs, transmitted via airborne droplets.
Asthma
This document provides information about asthma, including its definition, prevalence, pathophysiology, clinical manifestations, diagnostic studies, management, and nursing considerations. Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms of wheezing, breathlessness, chest tightness, and cough. It affects over 300 million people globally. Management involves both long-term control medications and quick-relief medications. The goals of nursing management are to stabilize respiratory status, relieve symptoms, reduce anxiety, promote health, prevent complications, and prevent further asthma episodes.
Asthma
Asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction. It affects 300 million people worldwide and poses a large socioeconomic burden. The disease severity can range from intermittent to persistent daily symptoms. Common triggers include allergens, infections, pollution, and exercise. Diagnosis involves assessing symptoms, lung function testing, and allergy testing. Treatment involves avoidance of triggers, bronchodilators for relief of acute symptoms, and anti-inflammatory controllers like inhaled corticosteroids to prevent symptoms and exacerbations.
Asthma Pathogenesis
This document summarizes the pathology of asthma. It describes the anatomical changes that occur, including epithelial desquamation, thickening of the lamina reticularis, smooth muscle hypertrophy and hyperplasia, mucous gland hyperplasia, and angiogenesis. It also discusses the multicellular inflammation in asthma involving eosinophils, mast cells, macrophages, dendritic cells, lymphocytes, and neutrophils. The roles of these inflammatory cells and their mediators in contributing to asthma pathogenesis are described.
What's hot (20)
Viewers also liked
Bronchial asthma and management RRT
Made by Ranjith R Thampi. A decent powerpoint on Bronchial Asthma, a short summary on various presentations and treatment options starting at Primary health level. Was made mainly for Primary Health setup. I've also added options at higher centres and also a few references for latest drug modalities and use.
Bronchial asthma
"Prevention is better than cure" so that,it is important to get awareness about bronchial asthma and its prevention.
Copd imp د. جيهان
The document discusses chronic obstructive pulmonary disease (COPD), including its definition as a progressive lung disease characterized by limited airflow; causes such as smoking, air pollution, and genetic factors; symptoms like breathlessness, cough, and sputum production; diagnostic tests and medical management including bronchodilators, antibiotics, and oxygen therapy; preventive measures like smoking cessation and flu vaccines; and nursing interventions focused on assessment, education, and managing complications. COPD encompasses chronic bronchitis and emphysema and is a serious lung condition caused primarily by smoking.
Chronic obstructive pulmonary disorders COPD
Chronic obstructive pulmonary disorders COPD is a [preventable and treatable disease with some significant extra pulmonary effects that may contribute to the severity in individual clients.
It is characterized by airflow limitation that is not completely reversible.
Nursing management of the client with increased intracranial pressure
The rigid cranial vault contains brain tissue (1,400 g), blood (75 mL), and CSF (75 mL)
The volume and pressure of these three components are usually in a state of equilibrium and produce the ICP.
ICP is usually measured in the lateral ventricles; normal ICP is 10 to 20 mm Hg. Increased ICP is a syndrome that affects many patients with acute neurologic conditions.
This is because pathologic conditions alter the relationship between intracranial volume and pressure. Although an elevated ICP is most commonly associated with head injury, it also may be seen as a secondary effect in other conditions, such as brain tumours, subarachnoid haemorrhage, and toxic and viral encephalopathies
Bronchiectasis
Bronchiectasis is a chronic lung condition defined by abnormal dilatation of the bronchi. It can be caused by infections, genetic conditions, or other lung diseases that damage the airways. People with bronchiectasis commonly produce large amounts of sputum and experience recurrent lung infections. Diagnosis is made through chest imaging like CT scans. Treatment focuses on airway clearance and controlling infections with antibiotics. Surgical options are available for severe cases involving hemorrhage or localized disease.
BRONCHIAL ASTHMA
This document provides an overview of bronchial asthma. It defines asthma as a chronic inflammatory disorder of the airways characterized by reversible airflow obstruction that causes symptoms like coughing, wheezing, chest tightness, and shortness of breath. Asthma is a chronic inflammatory lung disease that results in recurrent episodes of airflow obstruction that are usually reversible. The document discusses triggers of asthma and lists diagnostic tests like pulmonary function tests, serum immunoglobulin E tests, and computed tomography scans. It outlines the medical management goals for asthma and discusses drug therapy, dietary management, and surgical options. Nursing management of asthma includes patient education, activity pacing, oxygen therapy, and teaching about asthma triggers and proper inhaler usage.
Bronchiectasis
Bronchiectasis is a chronic lung condition characterized by abnormal dilation of the bronchi. It can be caused by airway obstruction, pulmonary infections, genetic disorders like cystic fibrosis, or idiopathic factors. Symptoms include persistent cough with large amounts of sputum, hemoptysis, and clubbing of the fingers. Diagnosis is made through chest imaging like HRCT. Treatment focuses on clearing secretions through postural drainage, chest physiotherapy, antibiotics, bronchodilators, and smoking cessation. Nursing management centers on helping patients perform breathing exercises and techniques to clear pulmonary secretions.
Upper respiratory disorders and nursing mangement
This document discusses nursing management of various respiratory disorders. It provides an overview of nursing assessment including history and physical assessment. It then discusses the etiology, pathophysiology, clinical manifestations, diagnosis and treatment of many respiratory conditions including upper respiratory tract infections, bronchitis, asthma, emphysema, pneumonia and others. It also reviews anatomy and physiology of the respiratory system and describes common diagnostic tests used to evaluate respiratory disorders.
Bronchial asthma
This document provides information on bronchial asthma including its definition, risk factors, triggers, pathophysiology, clinical manifestations, diagnostic findings, complications, prevention, medical management, nursing management, patient education, and status asthmaticus. It defines bronchial asthma as a chronic inflammatory disease of the airways and discusses allergies as the strongest predisposing factor. The document outlines objectives, assessments, treatments, and teaching points for managing patients with asthma or asthma exacerbations like status asthmaticus.
Dylan Presentation About Asthma
Asthma is a chronic disease that causes inflammation and narrowing of the airways, resulting in wheezing, chest tightness, shortness of breath, and coughing, especially at night or in the morning. An asthma attack occurs when the bronchial tubes swell and close, preventing enough air from reaching the body. Most asthma cases are hereditary and caused by genes, though exposure to tobacco smoke or a low-income environment can also increase children's risk. Asthma affects 300 million people worldwide and causes 255,000 deaths each year.
What is asthma how can asthma be prevented 1
Homeopathy can effectively treat asthma by addressing the underlying sensitivity and relieving both acute and chronic symptoms. It provides a safe, permanent cure without side effects, especially for children. Asthma causes wheezing, coughing, chest tightness and shortness of breath during attacks, which are often triggered by allergens, irritants, infections or stress. While lifestyle changes and avoiding triggers can help control asthma, homeopathic treatment works by reducing hypersensitivity and managing both acute flare-ups and long-term management.
Asthma Presentation 2
- Asthma is a chronic lung condition that affects over 3 million Canadians, with no cure but it can be managed. It involves inflammation and narrowing of the airways.
- Symptoms include coughing, shortness of breath, wheezing and chest tightness and are caused by bronchioconstriction in response to triggers.
- Asthma is treated through medications like rescue inhalers for sudden symptoms and controller medications taken daily to prevent symptoms, as well as avoiding triggers like allergens, infections and exercise. Proper management is key to living normally with asthma.
Chronic obstructive pulmonary disease (copd) power point
COPD is a chronic lung condition characterized by permanently narrowed airways and difficulty breathing. It encompasses chronic bronchitis and emphysema. COPD develops over many years as a result of lung damage, most commonly from cigarette smoking. It causes inflammation and narrowing of the airways and destruction of lung tissue over time. Symptoms include cough, wheezing, shortness of breath, and frequent respiratory infections. Treatment focuses on reducing symptoms, slowing lung function decline, and improving quality of life through medications, oxygen therapy, and smoking cessation.
Monographs api
This document provides information on the herbal drug Lasuna (garlic bulb) according to the Ayurvedic Pharmacopoeia of India. It describes the macroscopic and microscopic features of the garlic bulb and cloves. It also provides details on the identity, purity, strength and chemical constituents like volatile oil. The properties, important formulations, therapeutic uses and dosages are mentioned. Overall, the document concisely summarizes the key information about the herbal drug Lasuna as per the Ayurvedic standards.
Asthma
Asthma is a breathing disorder characterized by episodic shortness of breath, wheezing, cough, rapid pulse, and bluish lips or face. It is caused by inflammation of the airways that carry air into and out of the lungs, narrowing airflow. Symptoms can be triggered by allergens or other substances and are treated with drugs that widen the airways and reduce inflammation, such as inhalers, with the goal of controlling asthma and avoiding triggers. Physicians like chest doctors can diagnose and treat asthma based on symptoms, tests, and developing a treatment plan, although most cases are treatable at home.
Gina - global initiative against asthma
The document describes the Global Initiative for Asthma (GINA) program, which aims to increase awareness of asthma as a global health problem and provide evidence-based guidelines for diagnosis and management. GINA develops global strategy documents and provides resources to help implement asthma guidelines. The strategy follows a stepwise treatment approach based on asthma control levels to achieve treatment goals of control and prevention of exacerbations using inhaled corticosteroids and other controllers.
Bronchial Asthma in Pediatric
An old presentation that I made when I was an Intern in Pediatric department.
The presentation contains 71 slides. It discusses bronchial asthma in pediatric age group starting from the definition of bronchial asthma and its pathophysiology and ending by the management of acute attacks of asthma and long-term management of bronchial asthma patients.
Asthma
This document discusses bronchial asthma, including its definition, prevalence, etiology, triggers, pathogenesis, clinical features, classification of severity, diagnosis, investigations, management, pharmacotherapy, acute severe asthma/status asthmaticus, and considerations for dental treatment of asthmatic patients. Key points include that asthma is a chronic inflammatory disease characterized by reversible airway obstruction, it affects over 300 million people worldwide, treatment involves bronchodilators, corticosteroids, leukotriene antagonists and others to control symptoms and exacerbations, and special precautions should be taken when providing dental care to asthmatic patients to prevent triggering an attack.
Viewers also liked (20)
Nursing management of the client with increased intracranial pressure
Nursing management of the client with increased intracranial pressure
Chronic obstructive pulmonary disease (copd) power point
Chronic obstructive pulmonary disease (copd) power point
Similar to Asthma ppt
Asthma.pptx
Asthma is a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and cough. It involves intermittent and reversible airway obstruction, chronic bronchial inflammation with eosinophils, and increased mucus secretion. The hallmarks are bronchial smooth muscle hypertrophy/hyperreactivity and excessive TH2 reactions against environmental allergens leading to airway remodeling. Characteristic morphologic changes in asthma include thickening of the airway wall, sub-basement membrane fibrosis, increased vascularity, and increased mucus production.
Asthma
This document provides an overview of asthma including its definition, epidemiology, etiology, pathophysiology, clinical manifestations, investigations, and management. It defines asthma as a chronic inflammatory lung disease characterized by variable and recurring symptoms of wheezing, breathlessness, chest tightness, and coughing. Key points include that over 334 million people worldwide currently suffer from asthma, environmental factors like allergens and infections contribute to its development, and treatment involves management of symptoms and inflammation.
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
This document provides an overview of childhood asthma including its definition, epidemiology, etiology, pathogenesis, clinical manifestations, diagnosis and evaluation. Some key points:
- Asthma is a chronic inflammatory airway disease characterized by wheezing, breathlessness, chest tightness and cough.
- Global prevalence has increased 50% per decade, with higher rates in Western countries and urban areas. India has an estimated prevalence of 3%.
- It results from an interaction between genetic and environmental factors such as viruses, allergens, air pollution and tobacco smoke.
- Pathogenesis involves chronic airway inflammation and remodeling driven by T helper 2 cells and eosinophils in response to triggers.
Asthama ug ix term
Part 1 of Asthama Lecture for Final Year MBBS students
Definition, Pathophysiology, Pathology, History, Symptoms, Signs , Investigation. also see Part2
Pneumonia
THE slides cover all the basic information regarding pneumonia including nursing management#MEDICAL-SURGICAL NURSING
Asthma
This document provides an overview of asthma, including its history, symptoms, pathophysiology, diagnosis, and treatment. It begins with discussing the origins of the word asthma and key developments in understanding and treating the disease. The main symptoms of asthma are described as coughing, shortness of breath, wheezing, chest tightness, and inability to take in enough air. The document then covers the inflammatory process and histopathological features of asthma before moving to diagnostic tests like peak flow monitoring, spirometry, allergy skin tests, and chest x-rays. Finally, it outlines the main treatment approaches of avoiding triggers, using bronchodilators, corticosteroids, leukotriene antagonists, and mast
asthma-160507070255.pdf
The document provides an overview of asthma, including its history, symptoms, pathophysiology, diagnosis, and treatment. It defines asthma as a chronic inflammatory airway disease characterized by bronchial hyperresponsiveness. The symptoms of asthma include coughing, shortness of breath, wheezing, chest tightness, and inability to take in enough air. Diagnostic tests include peak flow testing, spirometry, allergy skin tests, and chest X-rays. Treatment involves education, avoidance of triggers, and medications like bronchodilators, corticosteroids, leukotriene antagonists, and mast cell stabilizers.
Pathophysiology asthma.
This document provides information on obstructive pulmonary diseases bronchial asthma and COPD. It defines bronchial asthma as a clinical condition characterized by chronic airway inflammation and hyperresponsiveness that causes symptoms like wheezing. The prevalence of asthma has increased worldwide to over 300 million cases. Genetics and environmental factors both contribute to its development and expression. COPD refers to both chronic bronchitis and emphysema. It involves pathological changes in the lungs like airway remodeling that make breathing difficult and lead to respiratory failure in severe cases.
Antiasthamatics
This ppt gives information about the introduction to asthma disease its causes, pathophysiology and classification of antiasthmetic drugs with its stucture , the ppt is made for basic knowledge of antiasthemetic drugs on medicinal chemistry point of veiw for B. pharmacy students.
pathophysiology & immunity of asthma
The document summarizes the correlation between the signs and symptoms of asthma and its pathophysiology and immune mechanisms. It discusses three components of asthma pathophysiology: 1) airway narrowing due to smooth muscle contraction, edema, and mucus plugging, 2) airway hyperresponsiveness caused by genetic and acquired factors, and 3) airway inflammation involving cytokines, mast cells, and other immune cells. The signs and symptoms of asthma including wheezing, breathlessness, coughing, and chest tightness correlate with the underlying pathophysiological processes of bronchospasm, airway remodeling, and inflammation.
Pathophysiology of Bronchial Asthma.....
This document summarizes respiratory pathophysiology related to bronchial asthma. It defines asthma as an episodic airway disease characterized by paroxysms of dyspnea, cough, and wheezing. It then discusses the prevalence of asthma and describes the three main types: extrinsic/allergic, intrinsic/non-atopic, and mixed. Extrinsic asthma is the most common type, triggered by allergens, while intrinsic asthma develops later in life and is not associated with allergies. Both types result in similar pathological changes in the lungs including mucus plugs, eosinophil infiltration, and airway wall thickening. Clinical features include acute exacerbations involving respiratory symptoms. Treatment focuses on reducing bronch
2.1. Bronchial asthma new.pptx
Asthma is a chronic inflammatory disease of the airways characterized by variable airflow obstruction. Key features include recurrent wheezing, breathlessness, chest tightness and cough. It affects over 100 million people worldwide. The pathogenesis involves airway inflammation driven by mast cells, eosinophils, macrophages and T lymphocytes activated by environmental and genetic factors. This leads to bronchial hyperresponsiveness and recurrent episodes of chest symptoms and airflow limitation. A diagnosis is made based on clinical history and objective tests showing variable expiratory airflow limitation that improves with bronchodilators.
Respiratory system
COPD is a group of pathological lung conditions characterized by chronic obstruction of airflow in the lungs. The main conditions included are chronic bronchitis, emphysema, asthma, and bronchiectasis. Chronic bronchitis involves persistent cough and mucus production. Emphysema results in the permanent enlargement of airspaces in the lungs. Cigarette smoking is the most common risk factor and causes damage through irritation, impaired clearance of mucus and toxins, and an imbalance of proteases and antiproteases in the lungs.
Important table
This document lists various bacterial organisms, the diseases they cause, and the reasons for pathogenesis. Staphylococcus aureus causes skin infections like boils and abscesses through exfoliative toxins and toxic shock syndrome toxin. Streptococcus pyogenes causes pharyngitis, pyogenic skin infections, scarlet fever, and rheumatic fever through various toxins and antibodies cross-reacting with tissues. Neisseria gonorrhoeae causes gonorrhea and related infections through invasion of tissues. Clostridium botulinum causes botulism through botulinum toxin.
RESPIRATORY SYSTEM PHAR KABSOM.ppt
The document discusses respiratory system pharmacology, focusing on bronchial asthma and COPD. It provides details on the causes, pathophysiology, and pharmacological treatment of these conditions. Specifically, it describes the classification and pathophysiology of asthma, including allergic and non-allergic types. It then outlines the goals of asthma management and discusses the classes of drugs used for treatment, including bronchodilators such as beta-2 agonists, anti-inflammatory agents like inhaled corticosteroids, and alternative therapies.
Gwen med surg pneumonia final
This document provides information on pneumonia and lung abscess from a seminar presentation. It begins with an introduction to pneumonia, defining it as an infection of the lungs. It then discusses the incidence of pneumonia globally and in various countries. Etiology, risk factors, pathophysiology, classification, signs and symptoms, complications, diagnosis, and management of pneumonia are explained. It also provides detail on lung abscess including definition, risk factors, pathophysiology, signs and symptoms, complications, diagnosis, and management. Surgical interventions for complications like empyema are also mentioned.
Asthma
This document provides information on asthma, including its definition, history, burden, types (atopic, non-atopic, drug-induced, occupational, exercise-induced), pathogenesis, genetic and environmental factors, clinical features, and methods of diagnosis. Asthma is a chronic airway disorder marked by episodic bronchoconstriction due to increased airway sensitivity and inflammation. It can be triggered by allergens, irritants, infections, and other stimuli and is characterized by symptoms like wheezing, coughing, and shortness of breath.
Bronchial asthma
The document discusses the etiology, pathophysiology, diagnosis and management of asthma. Some key points:
- Atopic allergy and allergy to common inhalants like house dust mites, pollens and molds contribute to 75-85% of asthma cases. Occupational allergens can also cause asthma.
- Pathophysiology involves airway smooth muscle contraction, epithelial secretions and inflammatory edema narrowing the airways. Early and late phase asthmatic reactions are mediated by IgE and inflammatory cells/mediators.
- Diagnosis involves assessing symptoms, lung function tests like spirometry, allergy tests and inflammation markers. Severity is classified based on symptoms, lung function
Asthma
Etiopathogenesis and pharmacotherapy of Asthma
the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and
monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
RESPIRATORY SYSTEM
The document discusses several respiratory conditions including pneumonia, tuberculosis, chronic obstructive pulmonary disease, and asthma. It provides details on the pathogenesis and morphology of pneumonia and tuberculosis, including the different types of pneumonia, typical causative organisms and clinical features. It also discusses the pathogenesis of tuberculosis, including how the bacteria infect macrophages and the immune response involving T helper 1 cells and granuloma formation. Chronic obstructive pulmonary disease and asthma are also briefly introduced.
Similar to Asthma ppt (20)
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
More from Delma Joie Magtubo,LPT, RN, MAN
Dep ed order no. 8 s. 2007
Revised Implementing Guidelines on the Operation and Management of School Canteens in Public Elementary and Secondary Schools
Elements of leadership part iii vision- delma joie magtubo
This document discusses vision statements and their importance for leadership. It defines a vision statement as answering the question "What will success look like?" and describes how a vision provides motivation by pursuing an image of success. A good vision is inspiring, exhilarating, competitive, original, unique, and helps prepare an organization for the future by reducing risk-taking. Benefits of a clear vision include motivating employees, clarifying long-term direction for executives, and representing integrity. Limitations can include a vision being too broad, uninspiring, indistinct, not forward-looking, or vague.
Elements of leadership part iv authority-delma joie magtubo
This document discusses different types of authority and leadership styles. It defines authority as the power formally given to an individual or group. There are five types of authority: legal, charismatic, competence, acceptance, and traditional. Four leadership styles are described based on authority: autocratic, democratic, free-rein, and paternalistic. Autocratic leadership relies on coercion and commands, while democratic leadership solicits participation. Free-rein leadership gives high independence, and paternalistic leadership treats followers like family. The advantages and disadvantages of each style are provided.
Florence Nightingale By Delma Joie D. Magtubo
Florence Nightingale developed her environmental theory based on her experiences as a nurse in the Crimean War, where she found unsanitary conditions led to high mortality rates. She believed the nurse's role was to control and manipulate a patient's environment to promote health and recovery. Her theory focuses on environmental factors like ventilation, light, cleanliness, noise levels and nutrition. Nightingale saw the environment as crucial to health and the nurse's job was to optimize it for each patient. Her theory provided the foundations for modern nursing practice and emphasized the nurse's role in prevention through environmental interventions.
Employee's Performance Evaluation
This document discusses the uses and process of performance appraisals in organizations. Performance appraisals are used to determine raises, bonuses, merit pay, and make personnel decisions regarding promotion, transfer, or dismissal. They also help identify training needs and are used for research purposes. The performance appraisal process involves setting standards, measuring and comparing performance to standards, discussing results, and making corrections. The document outlines advantages like providing performance feedback and opportunities for discussion, as well as disadvantages such as being time-consuming and subject to biases. Sources of appraisal include superiors, peers, subordinates, teams, and clients.
Meniere's Disease
Meniere's disease is an inner ear disorder characterized by episodes of vertigo, tinnitus, and fluctuating hearing loss. It was first described in 1861 by Prosper Meniere and is caused by endolymphatic hydrops, or a buildup of fluid in the inner ear. Risk factors include family history, head injuries, viral infections, and allergies. Symptoms include vertigo, tinnitus, and hearing loss. Treatment involves medications, diet modifications, vestibular rehabilitation therapy, and in severe cases surgery. Nursing management focuses on safety, administering medications, education, and rehabilitation exercises.
More from Delma Joie Magtubo,LPT, RN, MAN (6)
Elements of leadership part iii vision- delma joie magtubo
Elements of leadership part iii vision- delma joie magtubo
Elements of leadership part iv authority-delma joie magtubo
Elements of leadership part iv authority-delma joie magtubo
Recently uploaded
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Recently uploaded (20)
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Asthma ppt
- 1. By: Delma Joie D. Magtubo
- 3. ASTHMA An airflow obstruction caused by bronchoconstriction, which results from an allergic or hypersensitive reaction. ETIOLOGY/TYPES: 1. Extrinsic Asthma 2. Intrinsic Asthma
- 4. 1. Extrinsic Asthma 2. Intrinsic Asthma ETIOLOGY/TYPES: Allergy a. Genetically transmitted b. Childhood Onset UNKNOWN CAUSE
- 12. III. PATHOPHYSIOLOGY LIFTED FROM THE BOOK
- 13. III. Pathophysiology Non-modifiable Factors: >Gender >Family History Modifiable Factors: >Environmental Allergens >Emotional factors/Stress >GERD Triggers airway inflammation
- 14. III. Pathophysiology Release of mast cells, eosinophils, histamine, macrophages, and activated T lymphocytes Goblet cells mucus production Acute Bronchoconstriction
- 15. III. Pathophysiology Goblet cells mucus production Acute Bronchoconstriction COUGH Narrowing of the airway passages cWheezing
- 16. III. Pathophysiology Narrowing of the airway passages Difficulty Of Breathing ↓ Oxygenation c Chest Tightness c Wheezing
- 20. • HISTORY COLLECTION • PHYSICAL EXAMINATION • PULMONARY FUNCTION TEST • SERUM IMMUNOGLOBULIN E • SPUTUM ANALYSIS V. DIAGNOSTIC PROCEDURE
- 21. V. DIAGNOSTIC PROCEDURE • COMPUTED TOMOGRAPHY – HRCT • COMPLETE BLOOD COUNT • CHEST X-RAYS • ABG ANALYSIS • PULSE OXYMETRY
- 22. Also known as a “spacer” or valve holding chamber (VHC) Delivery of medication over 100% more effective
- 23. Used by some (usually moderate or severe) asthma patients to monitor ongoing lung function to detect changes
- 24. VI. MEDICAL AND SURGICAL MANAGEMENT
- 25. While asthma cannot be cured, it can be controlled: Medications ○Long term ○Quick relief ○Bronchial thermoplasty Learning to recognize one’s own triggers and taking steps to avoid them.
- 27. • Assess for breath sounds. • Assess the patient’s peak flow. • Monitor the patient’s vital signs. • Level of oxygen saturation through the pulse oximeter. • Respiratory status by monitoring the severity of the symptoms. Assessment of a patient with asthma includes the following:
- 38. “MAY 6TH 2014” LUNGS ASTHMA 5 6
- 39. THANK YOU